Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06696664
What this trial is testing

Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

Who this might be right for
Chronic Hepatitis B
Minghui Li 120
Early research (Phase 1)Ended earlyNCT05298332
What this trial is testing

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

Who this might be right for
Chronic Hepatitis b
Antios Therapeutics, Inc 37
Testing effectiveness (Phase 2)Study completedNCT04412863
What this trial is testing

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Vir Biotechnology, Inc. 84
Early research (Phase 1)Study completedNCT01641536
What this trial is testing

Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Genexine, Inc. 9
Post-approval studies (Phase 4)UnknownNCT02849132
What this trial is testing

Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients

Who this might be right for
Hepatitis BLiver Cirrhosis
Beijing Friendship Hospital 800
Early research (Phase 1)Ended earlyNCT05561530
What this trial is testing

ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 57
Not applicableStudy completedNCT02548325
What this trial is testing

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

Who this might be right for
Hepatitis B
Corporacion Parc Tauli 1,001
Large-scale testing (Phase 3)Study completedNCT01345240
What this trial is testing

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 705
Early research (Phase 1)Study completedNCT05960240
What this trial is testing

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Who this might be right for
Chronic Hepatitis b
Arbutus Biopharma Corporation 128
Post-approval studies (Phase 4)Study completedNCT00674908
What this trial is testing

Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Shantha Biotechnics Limited 144
Large-scale testing (Phase 3)Study completedNCT02060058
What this trial is testing

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT05330455
What this trial is testing

Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B
GlaxoSmithKline 74
Not applicableStudy completedNCT06793826
What this trial is testing

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Who this might be right for
Hepatitis BHaemophilus Influenzae Type b Immunisation
Sanofi Pasteur, a Sanofi Company 713
Not applicableLooking for participantsNCT06160635
What this trial is testing

D-SOLVE Cohorts (Cohort a and B)

Who this might be right for
HDVHDV InfectionChronic Liver Disease
Hannover Medical School 750
Not applicableActive Not RecruitingNCT07555340
What this trial is testing

A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B

Who this might be right for
HEPATITIS B CHRONIC
Juan Li 400
Testing effectiveness (Phase 2)Study completedNCT06644417
What this trial is testing

Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
HBV Infection With LLV
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Not applicableStudy completedNCT05117541
What this trial is testing

Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection

Who this might be right for
Chronic Viral HepatitisHepatitis B Infection
Thomas Jefferson University 365
Large-scale testing (Phase 3)Study completedNCT00023153
What this trial is testing

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Who this might be right for
HIV InfectionsChronic Hepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT00697931
What this trial is testing

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

Who this might be right for
Hepatitis B
GlaxoSmithKline 116
Next Page